Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

2.50
Delayed Data
As of 2:31pm ET
 +0.05 / +2.04%
Today’s Change
2.07
Today|||52-Week Range
5.55
+10.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2010
Quarter 4
2010
Quarter 1
2011
Quarter 2
2011
Revenue and IncomeNet Revenues136.0K45.0K37.0K22.0K
 
 
 
 
 
Cost of Goods Sold172.0K158.0K124.0K65.0K
 
 
 
 
 
 
Operating ExpensesGross Income-36.0K-113.0K-87.0K-43.0K
 
 
 
 
 
General Expenses3.4M3.4M2.5M3.2M
 
 
 
 
 
Other Operating Expenses554.0K0.000.000.00
 
 
Research And Development1.7M1.2M1.0M1.3M
 
 
 
 
 
Total Operating Expenses4.2M3.6M2.6M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-3.6M-2.6M-3.2M
 
 
 
 
 
Interest Expense On Debt--28.0K----
 
 
Other Expenses544.0K0.00822.0K421.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.5M-3.6M-1.8M-2.8M
 
 
 
 
 
Minority Interest-99.0K-69.0K-96.0K-261.0K
 
 
 
 
 
Discontinued Operations0.00-158.0K0.000.00
 
 
Net Income-3.4M-3.7M-1.7M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS281.5K295.3K395.9K76.1K
 
 
 
 
 
Shares To Calculate EPS Diluted281.5K295.3K395.9K76.1K
 
 
 
 
 
 
Earnings Per ShareEPS-$12.00-$12.60-$4.20--
 
 
 
 
EPS Diluted-$12.00-$12.60-$4.20-$33.00